Page 1 of 8 · 157 results
|
Symbol
|
Sector
|
Firm
|
Action
|
Grade
|
Target
|
Mkt Cap ▼
|
Base
|
Gap%
|
D1%
|
D2%
|
D3%
|
D4%
|
D5%
|
|
AMZN
|
Consumer Cyclical |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$2.9T
|
$146.09
|
-0.1%
|
+0.6%
|
-1.5%
|
+1.4%
|
-1.6%
|
+1.6%
|
|
AMZN
|
Consumer Cyclical |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$2.9T
|
$146.09
|
-0.1%
|
+0.6%
|
-1.5%
|
+1.4%
|
-1.6%
|
+1.6%
|
|
TSLA
|
Consumer Cyclical |
Goldman Sachs |
Maintains
|
Neutral
→
Neutral
|
—
|
$1.4T
|
$240.08
|
-2.9%
|
-0.5%
|
-1.4%
|
+1.3%
|
+0.3%
|
+1.4%
|
|
TSLA
|
Consumer Cyclical |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$1.4T
|
$240.08
|
-2.9%
|
-0.5%
|
-1.4%
|
+1.3%
|
+0.3%
|
+1.4%
|
|
TSLA
|
Consumer Cyclical |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$1.4T
|
$240.08
|
-2.9%
|
-0.5%
|
-1.4%
|
+1.3%
|
+0.3%
|
+1.4%
|
|
TSLA
|
Consumer Cyclical |
CFRA |
Maintains
|
Buy
→
Buy
|
—
|
$1.4T
|
$240.08
|
-2.9%
|
-0.5%
|
-1.4%
|
+1.3%
|
+0.3%
|
+1.4%
|
|
JNJ
|
Healthcare |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$558.8B
|
$154.66
|
+1.2%
|
+2.4%
|
+0.3%
|
-0.2%
|
-1.2%
|
-0.8%
|
|
JNJ
|
Healthcare |
UBSB |
Upgrade
|
Neutral
→
Buy
|
—
|
$558.8B
|
$154.66
|
+1.2%
|
+2.4%
|
+0.3%
|
-0.2%
|
-1.2%
|
-0.8%
|
|
BAC
|
Financial Services |
Goldman Sachs |
Maintains
|
Buy
→
Buy
|
—
|
$386.6B
|
$30.49
|
-0.3%
|
+1.5%
|
-0.5%
|
-0.8%
|
-0.2%
|
+0.4%
|
|
ABBV
|
Healthcare |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$376.6B
|
$142.39
|
+0.1%
|
+0.7%
|
+0.5%
|
+0.3%
|
+1.3%
|
+1.1%
|
|
BABA
|
Consumer Cyclical |
Morgan Stanley |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$324.7B
|
$74.88
|
-2.4%
|
-1.2%
|
-1.3%
|
-0.9%
|
-1.2%
|
+1.2%
|
|
WFC
|
Financial Services |
Goldman Sachs |
Maintains
|
Buy
→
Buy
|
—
|
$239.9B
|
$44.59
|
-0.2%
|
+1.0%
|
+0.2%
|
-1.4%
|
+0.0%
|
+2.0%
|
|
C
|
Financial Services |
Goldman Sachs |
Maintains
|
Neutral
→
Neutral
|
—
|
$232.5B
|
$46.10
|
-0.2%
|
+2.5%
|
+0.3%
|
-1.4%
|
+2.5%
|
+1.3%
|
|
MCD
|
Consumer Cyclical |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$201.2B
|
$281.84
|
+0.5%
|
+1.5%
|
+0.1%
|
+0.1%
|
+0.1%
|
-0.0%
|
|
NVO
|
Healthcare |
Argus |
Maintains
|
Buy
→
Buy
|
—
|
$197.0B
|
$101.84
|
-0.7%
|
-1.4%
|
+0.5%
|
-1.3%
|
-2.0%
|
-0.8%
|
|
CRM
|
Technology |
Argus |
Maintains
|
Buy
→
Buy
|
—
|
$171.5B
|
$251.90
|
-0.8%
|
+3.2%
|
-3.6%
|
+0.1%
|
-0.8%
|
-0.1%
|
|
APP
|
Technology |
UBS |
Maintains
|
Neutral
→
Neutral
|
—
|
$164.9B
|
$37.48
|
+0.5%
|
+2.1%
|
-2.3%
|
-0.8%
|
-1.3%
|
+0.7%
|
|
DELL
|
Technology |
Wells Fargo |
Maintains
|
Overweight
→
Overweight
|
—
|
$160.9B
|
$75.87
|
-5.3%
|
-5.2%
|
-3.6%
|
-0.0%
|
-2.4%
|
+1.4%
|
|
DELL
|
Technology |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$160.9B
|
$75.87
|
-5.3%
|
-5.2%
|
-3.6%
|
-0.0%
|
-2.4%
|
+1.4%
|
|
DELL
|
Technology |
Goldman Sachs |
Maintains
|
Buy
→
Buy
|
—
|
$160.9B
|
$75.87
|
-5.3%
|
-5.2%
|
-3.6%
|
-0.0%
|
-2.4%
|
+1.4%
|
Page 1 of 8 · 157 results